The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ib: Preliminary clinical activity and immune activation for NKTR-262 [TLR 7/8 agonist] plus NKTR-214 [CD122-biased agonist] in patients (pts) with locally advanced or metastatic solid tumors (REVEAL Phase Ib/II Trial).
 
Adi Diab
Consulting or Advisory Role - Celgene; CureVac; Nektar
Research Funding - Celgene (Inst); Idera (Inst); Nektar (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Nektar
 
Mario Marcondes
Employment - Nektar
Stock and Other Ownership Interests - Nektar
Honoraria - Nektar
Travel, Accommodations, Expenses - Nektar
 
Brian Kotzin
Employment - Nektar
Leadership - Rigel
Stock and Other Ownership Interests - AdMirX; Amgen; Gilead Sciences; Nektar; Rigel
Consulting or Advisory Role - AdMirX; Alder Biopharmaceuticals; Argenx; Delinia; ImmuNext; Innovative Science Solutions; Janssen; Just Biotherapeutics; Kyowa Hakko Kirin; Nektar; Rigel; Tizona Therapeutics, Inc.
 
Mary Ann Tagliaferri
Employment - Nektar
Leadership - Nektar
Stock and Other Ownership Interests - Nektar
Patents, Royalties, Other Intellectual Property - Nektar
Travel, Accommodations, Expenses - Nektar
 
Ute Hoch
Other Relationship - Nektar
 
Yunfeng Li
Employment - Nektar
Stock and Other Ownership Interests - Nektar
Honoraria - Nektar
Travel, Accommodations, Expenses - Nektar
 
Fiore Cattaruzza
Employment - Nektar
Stock and Other Ownership Interests - Nektar
Honoraria - Nektar
Travel, Accommodations, Expenses - Nektar
 
Jonathan Zalevsky
No Relationships to Disclose
 
Andrew Scott Brohl
Expert Testimony - GlaxoSmithKline (I)
 
James Brugarolas
Consulting or Advisory Role - Nektar
Research Funding - Genentech/Roche
Patents, Royalties, Other Intellectual Property - Patent of HIF-2 biomarker (Inst)
Other Relationship - Nektar
 
Mehmet Asim Bilen
Consulting or Advisory Role - Exelixis; Nektar; Sanofi
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Incyte (Inst); Nektar (Inst); Peleton (Inst); Pfizer (Inst); Seagen (Inst); Tricon Pharmaceuticals (Inst)
 
Shilpa Gupta
Stock and Other Ownership Interests - Nektar
Honoraria - Janssen Oncology
Consulting or Advisory Role - Exelixis; Genentech; Janssen Oncology; Merck; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Janssen Oncology
Research Funding - Astellas Medivation (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); MedImmune (Inst); Merck (Inst); Moderna Therapeutics (Inst); Pfizer (Inst)
 
Evidio Domingo Musibay
Consulting or Advisory Role - Immunocore
Research Funding - Prometheus (Inst)
 
Anthony Paul Conley
Consulting or Advisory Role - Nektar; Novartis
Research Funding - Ignyta; MedImmune (Inst)
Travel, Accommodations, Expenses - Nektar
 
Erkut Hasan Borazanci
Consulting or Advisory Role - Biogen (I); Fujifilm; Genzyme (I); Ipsen; Novartis (I); Teva (I)
Speakers' Bureau - Biogen (I); Genzyme (I); Ipsen; Novartis (I); Taiho Pharmaceutical; Teva (I)
Research Funding - Ambry Genetics (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Idera (Inst); Lilly (Inst); MabVax (Inst); Minneamrita Therapeutics (Inst); Pharmacyclics (Inst); Samumed (Inst)
 
Sandra P. D'Angelo
Consulting or Advisory Role - Amgen; EMD Serono; GlaxoSmithKline; Immune design; Nektar
Travel, Accommodations, Expenses - Adaptimmune; EMD Serono; Nektar
 
Brendan D. Curti
Consulting or Advisory Role - Alligator Bioscience; Eisai
Speakers' Bureau - Bristol-Myers Squibb; Prometheus
Research Funding - Bristol-Myers Squibb (Inst); Galectin Therapeutics (Inst); MedImmune (Inst); Prometheus (Inst); Viralytics (Inst)
Patents, Royalties, Other Intellectual Property - Biomarkers for OX40 response (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MedImmune; Prometheus